Caxton Associates (New York)’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-2,500
Closed -$891K 159
2014
Q1
$891K Buy
+2,500
New +$891K 0.05% 112